Mainz Biomed to Present Results of Pancreatic Cancer Verification Study at AACR 2026 Annual Meeting

At AACR the Company will present the results of its verification study evaluating a compact proprietary combination of ...

85 years of bold discovery: Texas Biomed marks milestone anniversary

Texas Biomedical Research Institute, one of the world's leading independent biomedical research institutions dedicated to eradicating infection and advancing health, is celebrating 85 years of bold ...

Orchestra BioMed to Receive Up to $21 Million in Proceeds from Acquisition of Vivasure by Haemonetics

$11 million in proceeds expected to be received during 2026, with remainder of expected proceeds to be received in future revenue earnouts Vivasure Medical Limited (“Vivasure”) has been a strategic ...

Biomed Industries Advances NA-931 Into Two Global Phase 3 Trials Alone and with Semaglutide and Tirzepatide for Obesity

Biomed Industries to Advance NA-931 Into Two Global Phase 3 Trials as Monotherapy and in Combination With Semaglutide and Tirzepatide for Obesity Advancing NA-931 into two Phase 3 programs as ...

BioMed Realty and TransMedics Announce 498,000-Square-Foot Lease at Assembly Innovation Park

Situated in Somerville's mixed-use urban development area known as Assembly Square, and with its close proximity to Interstate 93 and the MBTA Orange Line, Assembly Innovation Park offers exceptional ...

Assessing Orchestra BioMed Hldgs: Insights From 4 Financial Analysts

Analysts have set 12-month price targets for Orchestra BioMed Hldgs, revealing an average target of $14.5, a high estimate of ...

TD Cowen Initiates Orchestra BioMed (OBIO), Cites High-Margin Potential in Lead Cardiovascular Programs

Orchestra BioMed Holdings Inc. (NASDAQ:OBIO) is one of the best biotech penny stocks to buy according to analysts. On ...